Article Versions Notes

Öner İ, Anık H, Kurt İnci B, Kubilay Tolunay P, Ateş Ö, Yalçıntaş Arslan Ü, Karaçin C. A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapy. Medicina. 2025; 61(2):360. https://doi.org/10.3390/medicina61020360

Öner, İrem, Hicran Anık, Bediz Kurt İnci, Pınar Kubilay Tolunay, Öztürk Ateş, Ülkü Yalçıntaş Arslan, and Cengiz Karaçin. 2025. "A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapy" Medicina 61, no. 2: 360. https://doi.org/10.3390/medicina61020360

Öner, İ., Anık, H., Kurt İnci, B., Kubilay Tolunay, P., Ateş, Ö., Yalçıntaş Arslan, Ü., & Karaçin, C. (2025). A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapy. Medicina, 61(2), 360. https://doi.org/10.3390/medicina61020360